G
G
Genpact LimitedIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $1.3B ▼ | $268.98M ▼ | $147.99M ▲ | 11.42% ▲ | $0.87 ▲ | $227.88M ▲ |
| Q4-2025 | $1.32B ▲ | $284.5M ▲ | $143.09M ▼ | 10.85% ▼ | $0.83 ▼ | $200.72M ▼ |
| Q3-2025 | $1.29B ▲ | $278.01M ▲ | $145.83M ▲ | 11.29% ▲ | $0.84 ▲ | $229.41M ▲ |
| Q2-2025 | $1.25B ▲ | $270.67M ▲ | $132.72M ▲ | 10.58% ▼ | $0.76 ▲ | $216.27M ▲ |
| Q1-2025 | $1.21B | $245.29M | $130.85M | 10.77% | $0.75 | $214.14M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $928.08M ▼ | $5.62B ▼ | $3.14B ▼ | $2.48B ▼ |
| Q4-2025 | $1.2B ▲ | $5.84B ▲ | $3.29B ▲ | $2.55B ▲ |
| Q3-2025 | $740.76M ▲ | $5.36B ▲ | $2.82B ▲ | $2.54B ▼ |
| Q2-2025 | $663.26M ▲ | $5.31B ▲ | $2.72B ▲ | $2.59B ▲ |
| Q1-2025 | $561.62M | $4.89B | $2.44B | $2.45B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $147.99M ▲ | $-23.54M ▼ | $-31.45M ▲ | $-204.33M ▼ | $-275.76M ▼ | $-47.47M ▼ |
| Q4-2025 | $143.09M ▼ | $286.69M ▼ | $-371.86M ▼ | $208.81M ▲ | $113.07M ▲ | $269.04M ▼ |
| Q3-2025 | $145.83M ▲ | $308.36M ▲ | $-19.22M ▲ | $-208.96M ▼ | $77.5M ▼ | $292.02M ▲ |
| Q2-2025 | $132.72M ▲ | $177.37M ▲ | $-105.2M ▼ | $18.87M ▲ | $101.64M ▲ | $152.76M ▲ |
| Q1-2025 | $130.85M | $40.44M | $779K | $-125.54M | $-86.63M | $17.86M |
Revenue by Products
| Product | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|
Consumer And Healthcare | $430.00M ▲ | $430.00M ▲ | $450.00M ▲ | $450.00M ▲ |
Revenue by Geography
| Region | Q1-2019 | Q2-2019 | Q3-2019 | Q4-2019 |
|---|---|---|---|---|
Americas | $180.00M ▲ | $210.00M ▲ | $230.00M ▲ | $240.00M ▲ |
Asia Other Than India | $90.00M ▲ | $80.00M ▼ | $90.00M ▲ | $100.00M ▲ |
Europe | $100.00M ▲ | $110.00M ▲ | $100.00M ▼ | $110.00M ▲ |
INDIA | $440.00M ▲ | $490.00M ▲ | $470.00M ▼ | $490.00M ▲ |
Q1 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Genpact Limited's financial evolution and strategic trajectory over the past five years.
Genpact combines steady revenue growth, improving margins, and strong cash generation with a healthier, less leveraged balance sheet. Strategically, it benefits from deep process and industry expertise, a long-standing operational excellence culture, and a rapidly expanding AI and digital solutions portfolio supported by major cloud partnerships. These factors together create a business that is financially resilient and competitively differentiated within its chosen niches.
Key risks include rising overhead costs, the accounting opacity around R&D spending, and significant goodwill and intangible assets that depend on ongoing acquisition success. The company also operates in an intensely competitive and fast-changing technology landscape, where missteps in AI execution, pricing pressure, client insourcing, or sector-specific downturns could weigh on growth and margins. Shifts in capital allocation—such as pausing debt reduction or buybacks—add another layer of uncertainty around how future cash flows will be used.
The overall picture points to a company on an improving financial trajectory, using its balance sheet strength and cash flow to fund a strategic pivot toward AI-led, higher-value services. If Genpact can sustain its innovation pace, manage costs, and deepen its role in clients’ mission-critical operations, it is positioned for continued, though not risk-free, growth in both scale and profitability. Execution on its AI roadmap and disciplined capital allocation will be the main drivers of how favorable that future ultimately looks.
About Genpact Limited
https://www.genpact.comGenpact Limited provides business process outsourcing and information technology (IT) services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Banking, Capital Markets and Insurance; Consumer Goods, Retail, Life Sciences and Healthcare; and High Tech, Manufacturing and Services.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $1.3B ▼ | $268.98M ▼ | $147.99M ▲ | 11.42% ▲ | $0.87 ▲ | $227.88M ▲ |
| Q4-2025 | $1.32B ▲ | $284.5M ▲ | $143.09M ▼ | 10.85% ▼ | $0.83 ▼ | $200.72M ▼ |
| Q3-2025 | $1.29B ▲ | $278.01M ▲ | $145.83M ▲ | 11.29% ▲ | $0.84 ▲ | $229.41M ▲ |
| Q2-2025 | $1.25B ▲ | $270.67M ▲ | $132.72M ▲ | 10.58% ▼ | $0.76 ▲ | $216.27M ▲ |
| Q1-2025 | $1.21B | $245.29M | $130.85M | 10.77% | $0.75 | $214.14M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $928.08M ▼ | $5.62B ▼ | $3.14B ▼ | $2.48B ▼ |
| Q4-2025 | $1.2B ▲ | $5.84B ▲ | $3.29B ▲ | $2.55B ▲ |
| Q3-2025 | $740.76M ▲ | $5.36B ▲ | $2.82B ▲ | $2.54B ▼ |
| Q2-2025 | $663.26M ▲ | $5.31B ▲ | $2.72B ▲ | $2.59B ▲ |
| Q1-2025 | $561.62M | $4.89B | $2.44B | $2.45B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $147.99M ▲ | $-23.54M ▼ | $-31.45M ▲ | $-204.33M ▼ | $-275.76M ▼ | $-47.47M ▼ |
| Q4-2025 | $143.09M ▼ | $286.69M ▼ | $-371.86M ▼ | $208.81M ▲ | $113.07M ▲ | $269.04M ▼ |
| Q3-2025 | $145.83M ▲ | $308.36M ▲ | $-19.22M ▲ | $-208.96M ▼ | $77.5M ▼ | $292.02M ▲ |
| Q2-2025 | $132.72M ▲ | $177.37M ▲ | $-105.2M ▼ | $18.87M ▲ | $101.64M ▲ | $152.76M ▲ |
| Q1-2025 | $130.85M | $40.44M | $779K | $-125.54M | $-86.63M | $17.86M |
Revenue by Products
| Product | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|
Consumer And Healthcare | $430.00M ▲ | $430.00M ▲ | $450.00M ▲ | $450.00M ▲ |
Revenue by Geography
| Region | Q1-2019 | Q2-2019 | Q3-2019 | Q4-2019 |
|---|---|---|---|---|
Americas | $180.00M ▲ | $210.00M ▲ | $230.00M ▲ | $240.00M ▲ |
Asia Other Than India | $90.00M ▲ | $80.00M ▼ | $90.00M ▲ | $100.00M ▲ |
Europe | $100.00M ▲ | $110.00M ▲ | $100.00M ▼ | $110.00M ▲ |
INDIA | $440.00M ▲ | $490.00M ▲ | $470.00M ▼ | $490.00M ▲ |
Q1 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Genpact Limited's financial evolution and strategic trajectory over the past five years.
Genpact combines steady revenue growth, improving margins, and strong cash generation with a healthier, less leveraged balance sheet. Strategically, it benefits from deep process and industry expertise, a long-standing operational excellence culture, and a rapidly expanding AI and digital solutions portfolio supported by major cloud partnerships. These factors together create a business that is financially resilient and competitively differentiated within its chosen niches.
Key risks include rising overhead costs, the accounting opacity around R&D spending, and significant goodwill and intangible assets that depend on ongoing acquisition success. The company also operates in an intensely competitive and fast-changing technology landscape, where missteps in AI execution, pricing pressure, client insourcing, or sector-specific downturns could weigh on growth and margins. Shifts in capital allocation—such as pausing debt reduction or buybacks—add another layer of uncertainty around how future cash flows will be used.
The overall picture points to a company on an improving financial trajectory, using its balance sheet strength and cash flow to fund a strategic pivot toward AI-led, higher-value services. If Genpact can sustain its innovation pace, manage costs, and deepen its role in clients’ mission-critical operations, it is positioned for continued, though not risk-free, growth in both scale and profitability. Execution on its AI roadmap and disciplined capital allocation will be the main drivers of how favorable that future ultimately looks.

CEO
Balkrishan Kalra
Compensation Summary
(Year 2025)
Upcoming Earnings
ETFs Holding This Stock
Summary
Showing Top 3 of 294
Ratings Snapshot
Rating : A
Most Recent Analyst Grades
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:19.93M
Value:$656.6M
FMR LLC
Shares:19.89M
Value:$655.35M
VANGUARD GROUP INC
Shares:16.51M
Value:$543.91M
Summary
Showing Top 3 of 758

